These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 223774)

  • 1. [Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase].
    Salvayre R; Maret A; Nègre A; Douste-Blazy L
    C R Seances Acad Sci D; 1979 Mar; 288(12):995-8. PubMed ID: 223774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of multiple molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from normal and Fabry leukocytes.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Eur J Biochem; 1979 Oct; 100(2):377-83. PubMed ID: 41709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical study of unusual cases of Fabry disease].
    Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
    Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of N-acetyl-beta-D-glucosaminidase and alpha-galactosidase in liver diseases].
    Hempel A; Müller G; Hempel RD
    Z Gesamte Inn Med; 1981 Jul; 36(13):457-9. PubMed ID: 6269308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical diagnosis of Anderson-Fabry disease in two brothers].
    Vidershaĭn GIa; Beĭer EM; Mendel'son MM; Livandovskiĭ IuA
    Vopr Med Khim; 1986; 32(5):120-3. PubMed ID: 3095985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total activity and distribution of multiple forms of lysosomal glycosidases in subfractions of human leukocytes].
    Kuz'micheva NA; Vidershaĭn GIa
    Vopr Med Khim; 1984; 30(5):76-81. PubMed ID: 6241372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and properties of molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from blood lymphocytes and lymphoid cell lines transformed by Epstein-Barr virus.
    Salvayre R; Negre A; Maret A; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1981 Jun; 659(2):445-56. PubMed ID: 6266491
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysosomal enzyme activities among Chinese: leukocyte alpha-galactosidase and beta-galactosidase.
    Xu YK; Ng WG
    Hum Hered; 1988; 38(2):76-82. PubMed ID: 2837434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease].
    Salvayre R; Negre A; Maret A; Douste-Blazy L
    Pathol Biol (Paris); 1984 Apr; 32(4):269-84. PubMed ID: 6326022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of two forms of N-acetyl-alpha-galactosaminidase from human liver.
    Schram AW; De Groot PG; Hamers MN; Brouwer-Kelder B; Donker-Koopman WE; Tager JM
    Biochim Biophys Acta; 1978 Aug; 525(2):410-6. PubMed ID: 210819
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tissue distribution of the molecular forms of human alpha-galactosidase and N-acetyl-alpha-galactosaminidase].
    Salvayre R; Maret A; Negre A; Stebenet M; Douste-Blazy L
    Biochimie; 1979; 61(8):943-50. PubMed ID: 230858
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.
    Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC
    Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acid glycosidases in leukocytes of patients with chronic and acute myeloid leukemias].
    Minakova AL; Preobrazhenskaia ME; Khoroshko ND
    Vopr Med Khim; 1986; 32(2):114-8. PubMed ID: 3010566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and genetic studies in two families with Fabry disease.
    Goto I; Tabira T; Nawa A; Kurokawa T; Kuroiwa Y
    Arch Neurol; 1974 Jul; 31(1):45-50. PubMed ID: 4209573
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
    Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase.
    Garman SC; Garboczi DN
    J Mol Biol; 2004 Mar; 337(2):319-35. PubMed ID: 15003450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.
    Peltier A; Herbeuval E; Brondeau MT; Belleville F; Nabet P
    Biomedicine; 1977 May; 26(3):194-201. PubMed ID: 407951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.